Tag: MindMedicine - Page 2 - Psychedelic Alpha

Read more about the article MindMed Completes 1-for-15 Reverse Share Split

MindMed Completes 1-for-15 Reverse Share Split

Post published:August 27, 2022
Post category:Press Release

Read more about the article MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder

MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder

Post published:August 26, 2022
Post category:Press Release

Read more about the article MindMed Strengthens Board with Appointment of Two New Independent Directors

MindMed Strengthens Board with Appointment of Two New Independent Directors

Post published:August 12, 2022
Post category:Press Release

Read more about the article MindMed Reports Second Quarter 2022 Financial Results and Business Highlights

MindMed Reports Second Quarter 2022 Financial Results and Business Highlights

Post published:August 11, 2022
Post category:Press Release

Read more about the article MindMed Board of Directors Approves Reverse Share Split

MindMed Board of Directors Approves Reverse Share Split

Post published:August 5, 2022
Post category:Press Release

Read more about the article MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference

MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference

Post published:August 4, 2022
Post category:Press Release

Read more about the article Mindmed Announces Voting Results for Annual General and Special Meeting

Mindmed Announces Voting Results for Annual General and Special Meeting

Post published:June 1, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.